Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Adeno-Associated Viral Vectors Global Market Report 2025
Request Sample Buy Now
Global Adeno-Associated Viral Vectors Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Adeno-Associated Viral Vectors Global Market Report 2025

By Type Of Therapy (Gene Augmentation, Immunotherapy, Other Type Of Therapies), By Type Of Gene Delivery Method Used (Ex Vivo, In Vivo), By Target Therapeutic Area (Genetic Disorders, Hematological Disorders, Infectious Diseases, Metabolic Disorders, Ophthalmic Disorders, Muscle Disorders, Neurological Disorders, Other Target Therapeutic Areas ), By Scale Of Operation (Preclinical, Clinical, Commercial), By Application Area (Gene Therapy, Cell Therapy, Vaccines) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Adeno-Associated Viral Vectors Market Overview

• Adeno-Associated Viral Vectors market size has reached to $2.69 billion in 2024

• Expected to grow to $5.85 billion in 2029 at a compound annual growth rate (CAGR) of 16.6%

• Growth Driver: Rising Prevalence Of Genetic Disorders Fuels Growth In The Adeno-Associated Viral Vectors Market

• Market Trend: Advancements In Off-the-Shelf Rep/Cap Plasmids

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Adeno-Associated Viral Vectors Market?

Adeno-associated viral vectors (AAV) are small, non-pathogenic viruses commonly used in gene therapy. They are engineered to deliver therapeutic genes into target cells, offering potential treatments for genetic disorders, cancers, and other diseases. AAV's safety profile and ability to efficiently infect both dividing and non-dividing cells make them valuable tools in biomedical research and clinical applications.

The main type of adeno-associated viral vectors therapy are gene augmentation, immunotherapy, and others. Gene augmentation is a technique where a functional gene is introduced to replace or supplement a defective or missing gene in a patient's cells. The type of gene delivery method are ex vivo and in vivo, which works on target therapeutic areas such as genetic disorders, hematological disorders, infectious diseases, metabolic disorders, ophthalmic disorders, muscle disorders, neurological disorders, and others. The scale of operation includes preclinical, clinical, and commercial, applied for gene therapy, cell therapy, and vaccines.

Adeno-Associated Viral Vectors Market Size and growth rate 2025 to 2029: Graph

What Is The Adeno-Associated Viral Vectors Market Size 2025 And Growth Rate?

The adeno-associated viral vectors market size has grown rapidly in recent years. It will grow from $2.69 billion in 2024 to $3.17 billion in 2025 at a compound annual growth rate (CAGR) of 17.6%. The growth in the historic period can be attributed to vaccine development, increased funding and investment, academic and industrial collaborations, expansion of clinical trials, and public awareness and advocacy.

What Is The Adeno-Associated Viral Vectors Market Growth Forecast?

The adeno-associated viral vectors market size is expected to see rapid growth in the next few years. It will grow to $5.85 billion in 2029 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to expanding therapeutic applications, increasing the prevalence of genetic disorders, and neurological disorders, regulatory approvals and support, and cost reductions in production. Major trends in the forecast period include gene therapy advancements, technological innovations, scalable manufacturing processes, collaborations and investments, and technological advancements.

The forecast of 16.6% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. gene therapy programs by driving up the cost of AAV-based gene delivery systems sourced from Switzerland and Japan, exacerbating R&D expenses and delaying rare disease treatments. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Adeno-Associated Viral Vectors Market Segmented?

1) By Type Of Therapy: Gene Augmentation, Immunotherapy, Other Type Of Therapies

2) By Type Of Gene Delivery Method Used: Ex Vivo, In Vivo

3) By Target Therapeutic Area: Genetic Disorders, Hematological Disorders, Infectious Diseases, Metabolic Disorders, Ophthalmic Disorders, Muscle Disorders, Neurological Disorders, Other Target Therapeutic Areas

4) By Scale Of Operation: Preclinical, Clinical, Commercial

5) By Application Area: Gene Therapy, Cell Therapy, Vaccines

Subsegments:

1) By Gene Augmentation: Inherited Genetic Disorders, Muscular Dystrophy, Cystic Fibrosis, Hemophilia

2) By Immunotherapy: Cancer Immunotherapy, Viral Infections Immunotherapy, Autoimmune Diseases Immunotherapy

3) By Other Types Of Therapies: Gene Editing, RNA Therapy, Antiviral Therapy

What Is Driving The Adeno-Associated Viral Vectors Market? Rising Prevalence Of Genetic Disorders Fuels Growth In The Adeno-Associated Viral Vectors Market

The increasing prevalence of genetic disorders is expected to propel the growth of the adeno-associated viral vectors market going forward. Genetic disorders are conditions caused by abnormalities in an individual's DNA, leading to physical or developmental abnormalities. The improved diagnostic techniques, greater awareness, and higher reproductive age, along with environmental factors and genetic drift are leading to the rise in the prevalence of genetic disorders. Adeno-associated viral vectors are utilized in gene therapy for genetic disorders, delivering corrective genes into target cells to potentially treat conditions like muscular dystrophy or cystic fibrosis. For instance, in February 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, congenital diseases caused an estimated 240,000 baby deaths globally within 28 days of birth each year. An additional 170,000 children between the ages of 1 month and 5 years die as a result of congenital diseases. Therefore, the increasing prevalence of genetic disorders is driving the adeno-associated viral vectors industry.

Who Are The Major Players In The Global Adeno-Associated Viral Vectors Market?

Major companies operating in the adeno-associated viral vectors market are Pfizer Inc., Astellas Pharma, Biogen Inc., Charles River Laboratories International Inc., BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., PTC Therapeutics, Ultragenyx Pharmaceutical, Amicus Therapeutics Inc., Oxford Biomedica, Asklepios BioPharmaceutical Inc., uniQure biopharma B.V., Spark Therapeutics Inc., Akouos inc., Adverum Biotechnologies Inc., Passage Bio Inc., AVROBIO Inc, MeiraGTx Holdings plc, GenSight Biologics S.A., Freeline Therapeutics, Aspa Therapeutics Inc., Adrenas Therapeutics Inc., 4D Molecular Therapeutics, Abeona Therapeutics Inc., Neurophth Therapeutics

What Are The Key Trends Of The Global Adeno-Associated Viral Vectors Market? Advancements In Off-the-Shelf Rep/Cap Plasmids

Major companies operating in the adeno-associated viral vectors market are focusing on offering off-the-shelf availability of replication-capsid plasmid to gain a competitive edge in the market. Rep/Cap plasmids, commonly utilized in gene therapy for adeno-associated virus (AAV) vector production, are readily available from numerous commercial suppliers catering to molecular biology research needs. For instance, in January 2024, Charles River Laboratories International Inc., a US-based pharmaceutical company, introduced off-the-shelf replication-capsid plasmid range streamlines AAV-based gene therapy initiatives. This expansion of their product portfolio complements existing lentiviral packaging and AAV Helper plasmid offerings, cutting manufacturing efforts by as much as 66%. These ready-to-use plasmids undergo batch production with meticulous documentation, adhering to CMC guidelines and accompanied by Certification of Analysis (COA) to facilitate IND and Clinical Trial Application (CTA) submissions.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Adeno-Associated Viral Vectors Market? Merck KGaA Strengthens Life Sciences Portfolio With Acquisition Of Mirus Bio LLC

In May 2024, Merck KGaA, a Germany-based company that offers pharmaceuticals, biotechnology, and chemical materials acquired Mirus Bio LLC for $600 million. With this acquisition, Merck KGaA aims to enhance its capabilities in the life sciences sector by integrating Mirus Bio LLC’s advanced technologies for RNA-based research and therapeutic applications, thereby strengthening its position in the growing market for genetic engineering and biotechnology solutions, and furthering its commitment to developing innovative biopharmaceutical products. Mirus Bio LLC is a US-based company that offers adeno-associated viral (AAV) vectors and gene delivery technologies.

What Is The Regional Outlook For The Global Adeno-Associated Viral Vectors Market?

North America was the largest region in the adeno-associated viral vectors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Adeno-Associated Viral Vectors Market?

The adeno-associated viral vectors market consists of sales of recombinant adeno-associated viral vectors (AAV), serotype-specific adeno-associated viral vectors (AAV), and custom adeno-associated viral vectors (AAV). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Adeno-Associated Viral Vectors Industry?

The adeno-associated viral vectors market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the adeno-associated viral vectors industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Adeno-Associated Viral Vectors Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $3.17 billion
Revenue Forecast In 2034 $5.85 billion
Growth Rate CAGR of 16.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type Of Therapy: Gene Augmentation, Immunotherapy, Other Type Of Therapies
2) By Type Of Gene Delivery Method Used: Ex Vivo, In Vivo
3) By Target Therapeutic Area: Genetic Disorders, Hematological Disorders, Infectious Diseases, Metabolic Disorders, Ophthalmic Disorders, Muscle Disorders, Neurological Disorders, Other Target Therapeutic Areas
4) By Scale Of Operation: Preclinical, Clinical, Commercial
5) By Application Area: Gene Therapy, Cell Therapy, Vaccines Subsegments: 1) By Gene Augmentation: Inherited Genetic Disorders, Muscular Dystrophy, Cystic Fibrosis, Hemophilia
2) By Immunotherapy: Cancer Immunotherapy, Viral Infections Immunotherapy, Autoimmune Diseases Immunotherapy
3) By Other Types Of Therapies: Gene Editing, RNA Therapy, Antiviral Therapy
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Astellas Pharma, Biogen Inc., Charles River Laboratories International Inc., BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., PTC Therapeutics, Ultragenyx Pharmaceutical, Amicus Therapeutics Inc., Oxford Biomedica, Asklepios BioPharmaceutical Inc., uniQure biopharma B.V., Spark Therapeutics Inc., Akouos inc., Adverum Biotechnologies Inc., Passage Bio Inc., AVROBIO Inc, MeiraGTx Holdings plc, GenSight Biologics S.A., Freeline Therapeutics, Aspa Therapeutics Inc., Adrenas Therapeutics Inc., 4D Molecular Therapeutics, Abeona Therapeutics Inc., Neurophth Therapeutics
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Adeno-Associated Viral Vectors Market Characteristics

3. Adeno-Associated Viral Vectors Market Trends And Strategies

4. Adeno-Associated Viral Vectors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Adeno-Associated Viral Vectors Growth Analysis And Strategic Analysis Framework

5.1. Global Adeno-Associated Viral Vectors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Adeno-Associated Viral Vectors Market Growth Rate Analysis

5.4. Global Adeno-Associated Viral Vectors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Adeno-Associated Viral Vectors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Adeno-Associated Viral Vectors Total Addressable Market (TAM)

6. Adeno-Associated Viral Vectors Market Segmentation

6.1. Global Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gene Augmentation

Immunotherapy

Other Type Of Therapies

6.2. Global Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ex Vivo

In Vivo

6.3. Global Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Genetic Disorders

Hematological Disorders

Infectious Diseases

Metabolic Disorders

Ophthalmic Disorders

Muscle Disorders

Neurological Disorders

Other Target Therapeutic Areas

6.4. Global Adeno-Associated Viral Vectors Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Preclinical

Clinical

Commercial

6.5. Global Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gene Therapy

Cell Therapy

Vaccines

6.6. Global Adeno-Associated Viral Vectors Market, Sub-Segmentation Of Gene Augmentation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Inherited Genetic Disorders

Muscular Dystrophy

Cystic Fibrosis

Hemophilia

6.7. Global Adeno-Associated Viral Vectors Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cancer Immunotherapy

Viral Infections Immunotherapy

Autoimmune Diseases Immunotherapy

6.8. Global Adeno-Associated Viral Vectors Market, Sub-Segmentation Of Other Types Of Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gene Editing

RNA Therapy

Antiviral Therapy

7. Adeno-Associated Viral Vectors Market Regional And Country Analysis

7.1. Global Adeno-Associated Viral Vectors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Adeno-Associated Viral Vectors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Adeno-Associated Viral Vectors Market

8.1. Asia-Pacific Adeno-Associated Viral Vectors Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Adeno-Associated Viral Vectors Market

9.1. China Adeno-Associated Viral Vectors Market Overview

9.2. China Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Adeno-Associated Viral Vectors Market

10.1. India Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Adeno-Associated Viral Vectors Market

11.1. Japan Adeno-Associated Viral Vectors Market Overview

11.2. Japan Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Adeno-Associated Viral Vectors Market

12.1. Australia Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Adeno-Associated Viral Vectors Market

13.1. Indonesia Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Adeno-Associated Viral Vectors Market

14.1. South Korea Adeno-Associated Viral Vectors Market Overview

14.2. South Korea Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Adeno-Associated Viral Vectors Market

15.1. Western Europe Adeno-Associated Viral Vectors Market Overview

15.2. Western Europe Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Adeno-Associated Viral Vectors Market

16.1. UK Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Adeno-Associated Viral Vectors Market

17.1. Germany Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Adeno-Associated Viral Vectors Market

18.1. France Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Adeno-Associated Viral Vectors Market

19.1. Italy Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Adeno-Associated Viral Vectors Market

20.1. Spain Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Adeno-Associated Viral Vectors Market

21.1. Eastern Europe Adeno-Associated Viral Vectors Market Overview

21.2. Eastern Europe Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Adeno-Associated Viral Vectors Market

22.1. Russia Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Adeno-Associated Viral Vectors Market

23.1. North America Adeno-Associated Viral Vectors Market Overview

23.2. North America Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Adeno-Associated Viral Vectors Market

24.1. USA Adeno-Associated Viral Vectors Market Overview

24.2. USA Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Adeno-Associated Viral Vectors Market

25.1. Canada Adeno-Associated Viral Vectors Market Overview

25.2. Canada Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Adeno-Associated Viral Vectors Market

26.1. South America Adeno-Associated Viral Vectors Market Overview

26.2. South America Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Adeno-Associated Viral Vectors Market

27.1. Brazil Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Adeno-Associated Viral Vectors Market

28.1. Middle East Adeno-Associated Viral Vectors Market Overview

28.2. Middle East Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Adeno-Associated Viral Vectors Market

29.1. Africa Adeno-Associated Viral Vectors Market Overview

29.2. Africa Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Adeno-Associated Viral Vectors Market Competitive Landscape And Company Profiles

30.1. Adeno-Associated Viral Vectors Market Competitive Landscape

30.2. Adeno-Associated Viral Vectors Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Astellas Pharma Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. BioMarin Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Adeno-Associated Viral Vectors Market Other Major And Innovative Companies

31.1. Sarepta Therapeutics Inc.

31.2. PTC Therapeutics

31.3. Ultragenyx Pharmaceutical

31.4. Amicus Therapeutics Inc.

31.5. Oxford Biomedica

31.6. Asklepios BioPharmaceutical Inc.

31.7. uniQure biopharma B.V.

31.8. Spark Therapeutics Inc.

31.9. Akouos inc.

31.10. Adverum Biotechnologies Inc.

31.11. Passage Bio Inc.

31.12. AVROBIO Inc

31.13. MeiraGTx Holdings plc

31.14. GenSight Biologics S.A.

31.15. Freeline Therapeutics

32. Global Adeno-Associated Viral Vectors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Adeno-Associated Viral Vectors Market

34. Recent Developments In The Adeno-Associated Viral Vectors Market

35. Adeno-Associated Viral Vectors Market High Potential Countries, Segments and Strategies

35.1 Adeno-Associated Viral Vectors Market In 2029 - Countries Offering Most New Opportunities

35.2 Adeno-Associated Viral Vectors Market In 2029 - Segments Offering Most New Opportunities

35.3 Adeno-Associated Viral Vectors Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Adeno-Associated Viral Vectors Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Adeno-Associated Viral Vectors Market, Sub-Segmentation Of Gene Augmentation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Adeno-Associated Viral Vectors Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Adeno-Associated Viral Vectors Market, Sub-Segmentation Of Other Types Of Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Adeno-Associated Viral Vectors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Adeno-Associated Viral Vectors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Pfizer Inc. Financial Performance
  • Table 80: Astellas Pharma Financial Performance
  • Table 81: Biogen Inc. Financial Performance
  • Table 82: Charles River Laboratories International Inc. Financial Performance
  • Table 83: BioMarin Pharmaceutical Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Adeno-Associated Viral Vectors Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Adeno-Associated Viral Vectors Market, Sub-Segmentation Of Gene Augmentation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Adeno-Associated Viral Vectors Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Adeno-Associated Viral Vectors Market, Sub-Segmentation Of Other Types Of Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Adeno-Associated Viral Vectors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Adeno-Associated Viral Vectors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Pfizer Inc. Financial Performance
  • Figure 80: Astellas Pharma Financial Performance
  • Figure 81: Biogen Inc. Financial Performance
  • Figure 82: Charles River Laboratories International Inc. Financial Performance
  • Figure 83: BioMarin Pharmaceutical Inc. Financial Performance

Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

Read More About Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Read More About Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Musical Instruments Market 2023 – By Type (Stringed, Brass And Woodwind, Percussion, Keyboard), By Distribution Channel (Supermarkets\ Hypermarkets, Specialty Stores, Online Sales Channel), By Application (Commercial Eve...

View Report

Pharmaceutical Excipients Market 2023 – By Functionality (Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavoring Agents And Sweeteners, Disintegrants, Colorants, Lubricants And Glidants...

View Report

Retort Machine Global Market Report 2025 – By Process (Batch Sterilization, Continuous Sterilization), By Type (Saturated Steam, Water Immersion, Water Spray, Forced Steam Or Air), By End User (Food And Beverage Industry...

View Report

Automated Machine Learning (AutoML) Global Market Report 2025 – By Offering (Solutions, Services), By Deployment (Cloud, On-Premises), By Enterprise (Small And Medium Enterprise, Large Enterprise), By Application (Data P...

View Report

Antivirals Global Market Report 2025 – By Type (Branded, Generic), By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes), By Applic...

View Report

Knee Implants Global Market Report 2025 – By Product (Total Knee Replacement, Partial Knee Replacement, Revision Knee Replacement), By Component Type (Fixed-Bearing Implants, Mobile-Bearing Implants), By Material (Stainl...

View Report

Mannan Oligosaccharide Global Market Report 2025 – By Type (Food Grade, Feed Grade, Pharma Grade), By Application (Dietary Supplement, Medical Application, Veterinary Food, Other Applications), By End Use (Pet Food Indus...

View Report

Toluene Derivatives Global Market Report 2025 – By Type (Benzene, Xylene, Toluene Diisocyanate (TDI), Solvents, Surfactants, Polymers, Other Types), By Production Process (Selective Toluene Disproportionation, Transalkyl...

View Report

Frequently Asked Questions

Adeno-associated viral vectors (AAV) are small, non-pathogenic viruses commonly used in gene therapy. They are engineered to deliver therapeutic genes into target cells, offering potential treatments for genetic disorders, cancers, and other diseases. AAV's safety profile and ability to efficiently infect both dividing and non-dividing cells make them valuable tools in biomedical research and clinical applications. For further insights on this market, request a sample here

The market major growth driver - Rising Prevalence Of Genetic Disorders Fuels Growth In The Adeno-Associated Viral Vectors Market. For further insights on this market, request a sample here

The adeno-associated viral vectors market size has grown rapidly in recent years. It will grow from $2.69 billion in 2024 to $3.17 billion in 2025 at a compound annual growth rate (CAGR) of 17.6%. The growth in the historic period can be attributed to vaccine development, increased funding and investment, academic and industrial collaborations, expansion of clinical trials, and public awareness and advocacy. The adeno-associated viral vectors market size is expected to see rapid growth in the next few years. It will grow to " $5.85 billion in 2029 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to expanding therapeutic applications, increasing the prevalence of genetic disorders, and neurological disorders, regulatory approvals and support, and cost reductions in production. Major trends in the forecast period include gene therapy advancements, technological innovations, scalable manufacturing processes, collaborations and investments, and technological advancements. For further insights on this market, request a sample here

The adeno-associated viral vectorsmarket covered in this report is segmented –
1) By Type Of Therapy: Gene Augmentation; Immunotherapy; Other Type Of Therapies
2) By Type Of Gene Delivery Method Used: Ex Vivo; In Vivo
3) By Target Therapeutic Area: Genetic Disorders; Hematological Disorders; Infectious Diseases; Metabolic Disorders; Ophthalmic Disorders; Muscle Disorders; Neurological Disorders; Other Target Therapeutic Areas
4) By Scale Of Operation: Preclinical; Clinical; Commercial
5) By Application Area: Gene Therapy; Cell Therapy; Vaccines Subsegments:
1) By Gene Augmentation: Inherited Genetic Disorders; Muscular Dystrophy; Cystic Fibrosis; Hemophilia
2) By Immunotherapy: Cancer Immunotherapy; Viral Infections Immunotherapy; Autoimmune Diseases Immunotherapy
3) By Other Types Of Therapies: Gene Editing; RNA Therapy; Antiviral Therapy For further insights on this market, request a sample here

North America was the largest region in the adeno-associated viral vectors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adeno-associated viral vectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the adeno-associated viral vectors market are Pfizer Inc., Astellas Pharma, Biogen Inc., Charles River Laboratories International Inc., BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., PTC Therapeutics, Ultragenyx Pharmaceutical, Amicus Therapeutics Inc., Oxford Biomedica, Asklepios BioPharmaceutical Inc., uniQure biopharma B.V., Spark Therapeutics Inc., Akouos inc., Adverum Biotechnologies Inc., Passage Bio Inc., AVROBIO Inc, MeiraGTx Holdings plc, GenSight Biologics S.A., Freeline Therapeutics, Aspa Therapeutics Inc., Adrenas Therapeutics Inc., 4D Molecular Therapeutics, Abeona Therapeutics Inc., Neurophth Therapeutics. For further insights on this market, request a sample here.

Major trends in this market include Advancements In Off-the-Shelf Rep/Cap Plasmids. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Adeno-Associated Viral Vectors Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon